NORGES BANK

Bank

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1374170 OSLO, Q8

Position in EWTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$20,726,988

+$2,082,114 QoQ

Shares Held

510,140

-32.1% QoQ

Ownership

0.470%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 223 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. EWTX ranks #33 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,971,681	$1,476,123,103
2	REGN	Regeneron Pharmaceuticals, Inc.	1,172,808	$731,292,700
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,271,813	$683,883,867
4	BMRN	Biomarin Pharmaceutical Inc	8,207,954	$469,659,127
5	RVMD	Revolution Medicines, Inc.	2,157,479	$404,052,667
6	INSM	INSMED Inc	3,377,641	$360,124,083
7	ARWR	Arrowhead Pharmaceuticals, Inc.	3,896,536	$317,606,649
8	RPRX	Royalty Pharma plc	5,336,084	$299,194,229

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,726,988	510,140	-32.1%	Shares	Sole	2026-08-12
2025-12-31	$18,644,874	751,355	+1473.4%	Shares	Sole	2026-02-10
2025-06-30	$626,068	47,755	0.0%	Shares	Sole	2025-08-13
2025-03-31	$1,050,610	47,755	0.0%	Shares	Sole	2026-05-11
2024-12-31	$1,275,058	47,755	0.0%	Shares	Sole	2025-02-12
2024-09-30	$1,274,580	47,755	-84.2%	Shares	Sole	2025-11-12
2022-03-31	$2,926,402	301,691	0.0%	Shares	Sole	2023-05-12
2021-12-31	$4,609,838	301,691	0.0%	Shares	Sole	2022-03-09
2021-09-30	$5,008,070	301,691	0.0%	Shares	Sole	2022-11-14
2021-06-30	$6,435,069	301,691	-32.8%	Shares	Sole	2022-08-15
2021-03-31	$14,592,500	449,000	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.